Estimating the cost of treating patients with liver cirrhosis at the Mexican Social Security Institute

被引:0
|
作者
Esther Quiroz, Maria
Flores, Yvonne N. [1 ,2 ,3 ]
Aracena, Belkis [4 ]
Granados-Garcia, Victor [5 ]
Salmeron, Jorge
Perez, Ruth
Cabrera, Guillermo
Bastani, Roshan [2 ,3 ]
机构
[1] Inst Mexicano Seguro Social, Unidad Invest Epidemiol, Cuernavaca 62450, Morelos, Mexico
[2] UCLA Sch Publ Hlth, Los Angeles, CA USA
[3] Jonsson Comprehens Canc Ctr, Los Angeles, CA 90034 USA
[4] Inst Nacl Salud Publ, Cuernavaca, Morelos, Mexico
[5] Inst Mexicano Seguro Social, Ctr Med Nacl Siglo 21, Mexico City, DF, Mexico
来源
SALUD PUBLICA DE MEXICO | 2010年 / 52卷 / 06期
关键词
costs and cost analysis; liver cirrhosis; Mexico; HEPATOCELLULAR-CARCINOMA; DIABETES INCREASES; UNITED-STATES; HEPATITIS-C; CARE COSTS; MANAGEMENT; DISEASE; RISK; RECOMMENDATIONS; HYPERTENSION;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective. To estimate the annual cost of treating patients with cirrhosis at the Mexican Institute of Social Security (IMSS per its abbreviation in Spanish). Material and Methods. The annual cost of treating three stages of cirrhosis (Child-Pugh A, Child-Pugh B and Child-Pugh C) was estimated using micro-costing techniques and medical experts. These results were compared and contrasted with prices reported by IMSS. Results. The annual cost of treatment, in USA dollars, by Child-Pugh stage was: a) micro-costing results: $1 110.17 stage A, $549.55 stage B and $348.16 stage C; b) opinion of medical experts: $1 633.64, $6 564.04 and $19 660.35, respectively; and c) IMSS costs: $4 269.00, $16 949.63 and $30 249.25, respectively. Conclusions. The cost of treating patients with cirrhosis is considerable, and costs increase as the disease worsens. Cost estimates vary depending on the source of information, and the methodology used. There are discrepancies between the procedures reported in medical records and treatment recommendations by IMSS liver experts.
引用
收藏
页码:493 / 501
页数:9
相关论文
共 50 条
  • [41] Childhood Cancer Survival, 2006-2012 Cohorts of Mexican Institute of Social Security Beneficiaries at the Central-South Region of Mexico
    Castro-Rios, Angelica
    Martinez-Valverde, Silvia
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [42] Gender and age-related variations in human immunodeficiency virus infection trends at the Mexican Institute of Social Security: 2003-2017
    Murillo-Zamora, Efren
    Mendoza-Cano, Oliver
    Trujillo-Hernandez, Benjamin
    Delgado-Enciso, Ivan
    Guzman-Esquivel, Jose
    Ochoa-Castro, Maria R.
    Guzman-Solorzano, Jose A.
    GACETA MEDICA DE MEXICO, 2022, 158 (05): : 312 - 319
  • [43] Bronchial asthma healthcare costs in Mexico:: Analysis of trends from 1991-1996 with information from the Mexican Institute of Social Security
    Rico-Méndez, FG
    Barquera, S
    Cabrera, DA
    Escobedo, S
    Ochoa, LG
    Massey-Reynaud, LF
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2000, 10 (06) : 334 - 341
  • [44] Experience in liver transplantation (1996-2011) at the UMAE, General Hospital Gaudencio Gonzalez Garza, National Medical Center La Raza, Mexican Institute of Social Security, Mexico City, DF
    Mariano Hernandez-Dominguez, Jose
    Holm-Corzo, Alberto
    Santos-Caballero, Marlene
    Angel Porras-Ramos, Miguel
    Gomez-Casanova, Pedro
    Perez-Molina, Lorenzo
    Villasenor-Colin, Cesar
    Muniz-Toledo, Verulo
    Lopez-Sanchez, Hector
    Hernandez-Becerril, Hector
    Espinosa-Gonzalez, Alfonso
    Martinez-Jimenez, Oscar
    Torres-Amaya, Mario
    D'ector-Lira, Dulce
    Medina-Ramirez, Marino
    Sanabria-Trujillo, Giovanni
    Villafuerte-Munoz, Gloria
    Alanis-Jacobo, Verenice
    Rocha-Avila, Gustavo
    Zaldivar-Cervera, Jaime
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2011, 63 : 62 - 66
  • [45] Strengthening Essential Health Services Recovery Policy after the COVID-19 Pandemic. Evidence from the Mexican Institute of Social Security
    Doubova, Svetlana V.
    Contreras-Sanchez, Saul Eduardo
    Ascencio-Montiel, Ivan de Jesus
    Gonzalez-Leon, Margot
    Krug-Llamas, Ernesto
    Borrayo-Sanchez, Gabriela
    Bonifaz, Laura C.
    Aviles-Hernandez, Ricardo
    Duque-Molina, Celida
    Robledo-Aburto, Zoe
    ARCHIVES OF MEDICAL RESEARCH, 2024, 55 (05)
  • [46] Low-Cost Predictors for Liver Function and Clinical Outcomes after Sustained Virological Response in Patients with HCV-Related Cirrhosis and Thrombocytopenia
    Omer, Secil
    Iftime, Adrian
    Constantinescu, Ileana
    Dina, Ion
    MEDICINA-LITHUANIA, 2023, 59 (01):
  • [47] Cost analysis of drug treatment in hypertensive patients at social security health care family medicine units
    Figueroa-Garcia, Juan
    Granados-Garcia, Victor
    Roldan-Valadez, Ernesto
    Rojano-Mejia, David
    Enoc Cruz-Toledo, Jairo
    Palomo-Pinon, Silvia
    SALUD PUBLICA DE MEXICO, 2022, 64 (02): : 188 - 195
  • [48] Cost-effectiveness analysis on the surveillance for hepatocellular carcinoma in liver cirrhosis patients using contrast-enhanced ultrasonography
    Tanaka, Hironori
    Iijima, Hiroko
    Nouso, Kazuhiro
    Aoki, Noriaki
    Iwai, Takashi
    Takashima, Tomoyuki
    Sakai, Yoshiyuki
    Aizawa, Nobuhiro
    Iwata, Kazunari
    Ikeda, Naoto
    Iwata, Yoshinori
    Enomoto, Hirayuki
    Saito, Masaki
    Imanishi, Hiroyasu
    Nishiguchi, Shuhei
    HEPATOLOGY RESEARCH, 2012, 42 (04) : 376 - 384
  • [49] Comparative study of various glomerular filtration rate estimating equations in Egyptian patients with hepatitis C virus-related liver cirrhosis: a single-center observational study
    Abu El-Makarem, Mona Abd El-Rahman
    Mousa, Mahmoud Mohamed
    Ayaad, Lion Azer
    Keryakos, Hesham K. H.
    EGYPTIAN LIVER JOURNAL, 2021, 11 (01)
  • [50] Three years of COVID-19 in children that attend the Mexican Social Security Institute's 1,350 child day-care centers, 2020-2023
    Martinez-Valdez, Libny
    Richardson, Vesta L.
    Bautista-Marquez, Aurora
    Franco, Martin Alejandro Camacho
    Cruz, Vicente Cruz
    Avila, Mauricio Hernandez
    FRONTIERS IN PEDIATRICS, 2024, 11